Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inverness results

This article was originally published in The Tan Sheet

Executive Summary

FY 2003 net revenues jumped 42.5% to $296.4 mil., while fourth quarter net sales rose to $93.5 mil. from $65.1 mil in prior-year period, Inverness announces Feb. 18. The increases are primarily attributable to acquired businesses, the June launch of ClearBlue digital pregnancy test and the acquisition of Abbott Labs test kit lines, including Fact plus home pregnancy tests, Waltham, Mass.-based firm says. Inverness acquired products in September (1"The Tan Sheet" Oct. 6, 2003, p. 13)...

You may also be interested in...



Inverness Expands Home Pregnancy Market Share With Fact Plus Acquisition

Inverness Medical Innovations will immediately take over distribution of Abbott Labs' Fact plus OTC home pregnancy tests after acquiring the line along with several professional test kit products from the firm in a $92.5 mil. deal

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096509

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel